CHILDREN'S ADVIL ALLERGY SINUS
Clinical safety rating: caution
Comprehensive clinical and safety monograph for CHILDREN'S ADVIL ALLERGY SINUS (CHILDREN'S ADVIL ALLERGY SINUS).
Diphenhydramine: H1-receptor antagonist; centrally acting anticholinergic. Ibuprofen: Non-selective COX-1 and COX-2 inhibitor; inhibits prostaglandin synthesis. Phenylephrine: α1-adrenergic agonist; causes vasoconstriction.
| Metabolism | Diphenhydramine: extensively metabolized via CYP450 (CYP2D6) to diphenylmethoxyacetic acid and other metabolites. Ibuprofen: metabolized primarily via CYP2C9 to hydroxylated and carboxylated metabolites. Phenylephrine: metabolized via MAO-A and sulfation by SULT1A3 in gut and liver. |
| Excretion | Ibuprofen: Renal excretion of unchanged drug (10-20%) and metabolites (70-80%), with minor biliary/fecal elimination. Pseudoephedrine: Renal excretion of unchanged drug (70-90%), with remainder as inactive metabolites; dependent on urine pH. |
| Half-life | Ibuprofen: Terminal elimination half-life 2-4 hours in adults; in children 1-2 hours. Pseudoephedrine: Terminal elimination half-life 5-8 hours in adults, prolonged to 16-24 hours with alkaline urine; clinical context: duration of action correlates with half-life. |
| Protein binding | Ibuprofen: >99% bound to albumin; pseudoephedrine: negligible protein binding (less than 10%). |
| Volume of Distribution | Ibuprofen: 0.1-0.2 L/kg (low, reflecting high protein binding); pseudoephedrine: 2.6-3.5 L/kg (moderate, indicating tissue distribution). |
| Bioavailability | Ibuprofen: Oral bioavailability 80-100% (extensive absorption). Pseudoephedrine: Oral bioavailability 100% (complete absorption). |
| Onset of Action | Oral: Ibuprofen onset of analgesia 30-60 minutes; pseudoephedrine onset of decongestant effect 15-30 minutes. |
| Duration of Action | Oral: Ibuprofen duration of analgesia 4-6 hours; pseudoephedrine duration of decongestant effect 4-6 hours, with extended-release formulations up to 12 hours. Note: individual variation and dose-dependent. |
Not applicable (pediatric formulation). For adult equivalent: ibuprofen 200-400 mg PO q6h PRN; chlorpheniramine 4 mg PO q4-6h PRN; pseudoephedrine 60 mg PO q4-6h PRN.
| Dosage form | SUSPENSION |
| Renal impairment | Ibuprofen: eGFR <30 mL/min: avoid use. Pseudoephedrine: eGFR <30 mL/min: reduce dose or extend interval; CrCl <10 mL/min: avoid use. Chlorpheniramine: eGFR <10 mL/min: use with caution. |
| Liver impairment | Ibuprofen: Child-Pugh C: avoid use. Pseudoephedrine: Child-Pugh C: caution, reduce dose. Chlorpheniramine: Child-Pugh C: reduce dose or avoid. |
| Pediatric use | Ibuprofen: 5-10 mg/kg/dose q6-8h PRN; max 40 mg/kg/day. Chlorpheniramine: 0.35 mg/kg/day divided q6h; max 12 mg/day. Pseudoephedrine: 1 mg/kg/dose q6h PRN; max 4 mg/kg/day. |
| Geriatric use | Ibuprofen: initiate at lowest effective dose; monitor renal function and GI adverse effects. Chlorpheniramine: avoid due to anticholinergic effects. Pseudoephedrine: start at lower doses; monitor for hypertension and CNS stimulation. |
| 1st trimester | Consult provider |
| 2nd trimester | Consult provider |
| 3rd trimester | Consult provider |
Clinical note
Comprehensive clinical and safety monograph for CHILDREN'S ADVIL ALLERGY SINUS (CHILDREN'S ADVIL ALLERGY SINUS).
| Breastfeeding | Ibuprofen: Low levels in breast milk (M/P ratio ~0.01 considered safe). Pseudoephedrine: Excreted in breast milk (M/P ratio ~2.6-3.5); may reduce milk production and cause irritability in infants. Use with caution. |
| Teratogenic Risk | First trimester: Avoid NSAIDs (ibuprofen) due to possible increased risk of cardiac defects and gastroschisis; limited data on pseudoephedrine suggests no major teratogenicity. Second trimester: Ibuprofen use associated with fetal renal dysfunction and oligohydramnios; pseudoephedrine may cause fetal tachycardia. Third trimester: NSAIDs (ibuprofen) contraindicated due to risk of premature closure of ductus arteriosus, oligohydramnios, and necrotizing enterocolitis; pseudoephedrine may cause uterine artery vasoconstriction and fetal hypoxia. |
■ FDA Black Box Warning
None
| Serious Effects |
Hypersensitivity to any component. Concomitant use with MAO inhibitors or within 14 days (hypertensive crisis). Severe hypertension, coronary artery disease, narrow-angle glaucoma, urinary retention, peptic ulcer disease, gastrointestinal bleeding. Children <12 years (unless directed by doctor).
| Precautions | Cardiovascular effects: avoid with hypertension, heart disease, hyperthyroidism; risk of vasoconstriction, tachycardia. CNS depression: avoid with sedatives, alcohol; may cause drowsiness. Gastrointestinal bleeding: NSAIDs increase risk of serious GI events. Reye syndrome: do not use in children with varicella or influenza-like illness due to diphenhydramine component? (Note: Risk primarily with aspirin; still caution). Anticholinergic effects: caution with asthma, glaucoma, prostatic hypertrophy, urinary retention. Hepatic/renal impairment: risk of toxicity. |
| Food/Dietary | Avoid alcohol. Take with food or milk to reduce GI upset. Grapefruit juice may increase ibuprofen absorption. |
Loading safety data…
| Fetal Monitoring | Monitor for oligohydramnios and ductus arteriosus patency by ultrasound if ibuprofen used beyond 20 weeks. Assess fetal heart rate for tachycardia with pseudoephedrine. Monitor maternal blood pressure and renal function. |
| Fertility Effects | Ibuprofen may transiently impair fertility via inhibition of ovulation (reversible). Pseudoephedrine: No known direct effect on fertility. |
| Clinical Pearls | CHILDREN'S ADVIL ALLERGY SINUS contains ibuprofen (NSAID) and diphenhydramine (first-generation antihistamine). Avoid in children <6 months. Monitor for CNS depression and anticholinergic effects. Use with caution in asthma, renal impairment, or bleeding disorders. |
| Patient Advice | Do not exceed 4 doses in 24 hours. · Do not use with other products containing diphenhydramine or ibuprofen. · May cause drowsiness; avoid activities requiring alertness. · Discontinue and seek medical attention if allergic reaction or stomach pain occurs. · Store at room temperature away from moisture and heat. |